KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Non Operating Income (2017 - 2024)

Elanco Animal Health (ELAN) has disclosed Non Operating Income for 8 consecutive years, with -$1.0 million as the latest value for Q3 2024.

  • Quarterly Non Operating Income rose 88.89% to -$1.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$46.0 million through Sep 2024, up 25.81% year-over-year, with the annual reading at -$75.0 million for FY2023, 134.38% down from the prior year.
  • Non Operating Income hit -$1.0 million in Q3 2024 for Elanco Animal Health, up from -$2.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $115.0 million in Q3 2020 to a low of -$34.0 million in Q4 2023.
  • Historically, Non Operating Income has averaged $3.0 million across 5 years, with a median of -$5.0 million in 2022.
  • Biggest five-year swings in Non Operating Income: soared 1330.77% in 2020 and later plummeted 800.0% in 2022.
  • Year by year, Non Operating Income stood at $16.0 million in 2020, then plummeted by 81.25% to $3.0 million in 2021, then tumbled by 800.0% to -$21.0 million in 2022, then tumbled by 61.9% to -$34.0 million in 2023, then surged by 97.06% to -$1.0 million in 2024.
  • Business Quant data shows Non Operating Income for ELAN at -$1.0 million in Q3 2024, -$2.0 million in Q2 2024, and -$9.0 million in Q1 2024.